Recent research demonstrates that individuals harboring BRCA2 mutations have a higher risk of developing male breast cancer, prostate cancer, and pancreatic cancer than those with BRCA1 mutations [72]. The gene discussed is BRCA2; the disease is prostate carcinoma.